AWH reports advisory board consulting for Johnson & Johnson Innovative Medicine, Intellisphere, Exelixis, Eisai, and Pfizer; honoraria from Medscape and Binaytara Foundation; travel support from DAVA Oncology, and institutional research funding from Bayer and Eisai. VK reports consulting for Janssen Oncology, Pfizer, Regeneron, Merck, Myovant, Eisai, Aveo, AstraZeneca, Xencor, and Exelixis; and institutional research funding from Pfizer, Merck, Janssen, Xencor, Bristol-Myers Squibb, and Regeneron. AA reports consulting for Amgen, Astellas Pharma, Astra Zeneca Pharmaceuticals, Bayer, Bristol-Myers Squibb Pharmaceuticals, Daiichi Sankyo, Genzyme, Janssen Pharmaceuticals, Pfizer, and Sanofi; and institutional research funding from AstraZeneca Pharmaceuticals, Janssen Pharmaceuticals, and Polaris Pharmaceuticals.